Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Spanish investigators discover novel antihypertensive agent

Nov. 21, 1996

Chiesi reports pharmacological profile of CHF-2363

Nov. 21, 1996

Merck & Co. launches Hyzaar in France

Nov. 21, 1996

Potent and selective PAF antagonist from Uriach

Nov. 21, 1996

TBC-11251 enters clinical trials

Nov. 20, 1996

Completion of phase IIa trials with CytoTAb in sepsis

Nov. 19, 1996

ET antagonists revealed by SmithKline Beecham

Nov. 19, 1996

Hyal and The Hospital for Sick Children vascular disease collaboration

Nov. 15, 1996

Cypros acquires well-established Rx for esophageal varices

Nov. 15, 1996

Human pharmacokinetic/pharmacodynamic studies on bosentan

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...